approved EB-2 (NIW)

Assay Development Scientist

Molecular Biology · India · 2022-04-21

Processing Time
80 days
Decision Date
2022-04-21
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on the application of immunological and point-of-care-based assays to develop low-cost tools for diagnosing infectious diseases. This work aims to mitigate the public health impact of infectious diseases through accessible diagnostic technology.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research related to developing low-cost tools for diagnosing infectious diseases was found to have great substantial merit and national importance.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to 11 years of research experience, 14 publications, and 249 citations.

3 Waiver Benefit Met

The case demonstrated that it would be beneficial to the United States to waive the job offer and labor certification requirements.

Why This Petition Was Approved

The petition was approved based on the petitioner's 14 peer-reviewed journal articles (6 first-authored) and 249 citations. Additionally, the petitioner demonstrated expertise through 20 peer reviews and 11 years of research experience, supported by 2 expert recommendation letters.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Original Contributions
Judging Experience

Similar Cases

Laboratory Technician

Biotechnology · Ethiopia

WeGreened EB-2 (NIW) rfe approved
Maryland 411 days 2025-07-09
The petitioner proposes to continue his research on the development and validation of diagnostic assays to accurately identify infectious pathogens. These assays are intended for point-of-care testing, disease outbreak surveillance, and supporting clinical vaccine and drug trials. The work aims to improve the speed and accuracy of pathogen detection to enhance disease management and public health protection.

Lecturer

Biotechnology · Vietnam

WeGreened EB-2 (NIW) approved
63 days 2023-02-22
The petitioner proposes to continue her research on investigating quality control techniques, in vitro diagnostic tests, and antiviral/antibacterial drugs. Her work focuses on developing novel approaches for combating emerging infectious diseases, specifically advancing PCR protocols and diagnostic procedures.

Doctor

Healthcare · Venezuela

WeGreened EB-2 (NIW) rfe approved
New York 169 days 2025-07-22
The petitioner proposes to advance research on infectious diseases, specifically focusing on generating clinical data regarding screening, immunity levels, and outcomes. His work aims to improve early diagnosis and prevention strategies to reduce public health risks and improve patient outcomes in the U.S. healthcare system.

Research Scientist

Research and Development · India

WeGreened EB-2 (NIW) approved
Georgia 68 days 2025-02-27
The petitioner proposes to develop diagnostic assays and platforms to study infectious viruses to enable rapid containment of emerging diseases. This work focuses on advancing tools for the detection of viral pathogens and supporting antiviral and vaccine efficacy testing.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-21.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 80 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist